138 related articles for article (PubMed ID: 25450736)
1. [Injectable hemostatic sponges XStat™: revolution or gadget?].
Hoffmann C; Falzone E; Martinez T; Boutonnet M; Peigne V; Lenoir B
Ann Fr Anesth Reanim; 2014 Nov; 33(11):605-6. PubMed ID: 25450736
[No Abstract] [Full Text] [Related]
2. Injectable hemostatic adjuncts in trauma: Fibrinogen and the FIinTIC study.
Maegele M; Zinser M; Schlimp C; Schöchl H; Fries D
J Trauma Acute Care Surg; 2015 Jun; 78(6 Suppl 1):S76-82. PubMed ID: 26002269
[No Abstract] [Full Text] [Related]
3. [Bleeding time and hemostatic agents].
Roskam J
Rev Med Liege; 1973 Aug; 28(16):565-8. PubMed ID: 4755005
[No Abstract] [Full Text] [Related]
4. [Medical hemostasis. I. the treatment of hemorrhages and hemorrhagic diathesis in veterinary practice].
van den Bogaard AE
Tijdschr Diergeneeskd; 1989 Feb; 114(3):136-45. PubMed ID: 2646756
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of US military transfusion support for resuscitation of trauma and hemorrhagic shock].
Prat N; Pidcoke HF; Sailliol A; Cap AP
Transfus Clin Biol; 2013 May; 20(2):225-30. PubMed ID: 23597584
[TBL] [Abstract][Full Text] [Related]
6. Successful use of a military-grade haemostatic agent for a major head and neck bleed.
Crunkhorn R; Burnham R; Walton G
J Laryngol Otol; 2013 Oct; 127(10):1031-3. PubMed ID: 24059601
[TBL] [Abstract][Full Text] [Related]
7. Prohemostatic interventions in trauma: resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other hemostatic interventions.
Howard BM; Daley AT; Cohen MJ
Semin Thromb Hemost; 2012 Apr; 38(3):250-8. PubMed ID: 22467527
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic effects of microfibrillar collagen hemostat (MCH) in experimental coagulopathy model and its mechanism of hemostasis.
Hatsuoka M; Seiki M; Sasaki K; Kashii A
Thromb Res; 1986 May; 42(3):407-12. PubMed ID: 3520941
[No Abstract] [Full Text] [Related]
9. Coagulation management in massive bleeding.
Griffee MJ; Deloughery TG; Thorborg PA
Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
[TBL] [Abstract][Full Text] [Related]
10. Exsanguination in trauma: A review of diagnostics and treatment options.
Geeraedts LM; Kaasjager HA; van Vugt AB; Frölke JP
Injury; 2009 Jan; 40(1):11-20. PubMed ID: 19135193
[TBL] [Abstract][Full Text] [Related]
11. Alternative and topical approaches to treating the massively bleeding patient.
Kulkarni R
Clin Adv Hematol Oncol; 2004 Jul; 2(7):428, 431. PubMed ID: 16163216
[No Abstract] [Full Text] [Related]
12. [Drug therapy of hemorrhagic syndromes. Part I].
Ballerini G
Clin Ter; 1974 Jul; 70(2):117-45. PubMed ID: 4409281
[No Abstract] [Full Text] [Related]
13. Hemorrhage control in the battlefield: role of new hemostatic agent.
Wortham L
Mil Med; 2005 Dec; 170(12):ii; author reply ii, 1004. PubMed ID: 16491933
[No Abstract] [Full Text] [Related]
14. [Fibrinogen--critical factor in massive bleeding. A retrospective study of management in trauma].
Erlandsson E; Winstedt D; Tornqvist F; Frigyesi A; Schött U
Lakartidningen; 2011 Nov 2-8; 108(44):2219-23. PubMed ID: 22165181
[No Abstract] [Full Text] [Related]
15. The Effect of Haemostatic Dressing Prototypes for the Emergency Services in the Porcine Haemostatic System.
Adamiak Z; Borys J; Krystkiewicz W; Pomaniowski A; Jalynski M; Holak P; Brzezinski M; Jastrzebski P; Tobolska A; Glodek J
In Vivo; 2019; 33(2):359-363. PubMed ID: 30804113
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
17. Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation.
Dargaud Y; Jourdy Y; Le Quellec S; Hemker CH; Lindhout T; Castoldi E; Negrier C
Br J Haematol; 2016 Sep; 174(6):993-6. PubMed ID: 26517807
[No Abstract] [Full Text] [Related]
18. Recent developments in topical thrombins.
Kessler CM; Ortel TL
Thromb Haemost; 2009 Jul; 102(1):15-24. PubMed ID: 19572062
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
20. Laboratory Assessment of Hemostatic and Anticoagulant Therapy.
Adcock DM; Gosselin RC
Semin Thromb Hemost; 2017 Apr; 43(3):242-244. PubMed ID: 28346961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
